First Time Loading...

Qiagen NV
NYSE:QGEN

Watchlist Manager
Qiagen NV Logo
Qiagen NV
NYSE:QGEN
Watchlist
Price: 42.75 USD 0.12% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. [ Read More ]

The intrinsic value of one QGEN stock under the Base Case scenario is 41.48 USD. Compared to the current market price of 42.75 USD, Qiagen NV is Overvalued by 3%.

Key Points:
QGEN Intrinsic Value
Base Case
41.48 USD
Overvaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Qiagen NV

Backtest QGEN Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling QGEN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Qiagen NV's business.

What risks and challenges
does Qiagen NV face in the near future?

Summarize the latest earnings report
of Qiagen NV.

Provide P/E
for Qiagen NV and its competitors.

Financials

Balance Sheet Decomposition
Qiagen NV

Current Assets 2.1B
Cash & Short-Term Investments 1.1B
Receivables 396.9m
Other Current Assets 692.9m
Non-Current Assets 4B
Long-Term Investments 20.6m
PP&E 765m
Intangibles 3B
Other Non-Current Assets 179.4m
Current Liabilities 1.1B
Accounts Payable 84.2m
Accrued Liabilities 325.1m
Other Current Liabilities 670.1m
Non-Current Liabilities 1.2B
Long-Term Debt 921.8m
Other Non-Current Liabilities 306.3m
Efficiency

Earnings Waterfall
Qiagen NV

Revenue
2B USD
Cost of Revenue
-731.6m USD
Gross Profit
1.2B USD
Operating Expenses
-788.4m USD
Operating Income
445.2m USD
Other Expenses
-103.9m USD
Net Income
341.3m USD

Free Cash Flow Analysis
Qiagen NV

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

QGEN Profitability Score
Profitability Due Diligence

Qiagen NV's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

59/100
Profitability
Score

Qiagen NV's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

QGEN Solvency Score
Solvency Due Diligence

Qiagen NV's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
High Altman Z-Score
Long-Term Solvency
79/100
Solvency
Score

Qiagen NV's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

QGEN Price Targets Summary
Qiagen NV

Wall Street analysts forecast QGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QGEN is 52.02 USD with a low forecast of 44.25 USD and a high forecast of 63 USD.

Lowest
Price Target
44.25 USD
4% Upside
Average
Price Target
52.02 USD
22% Upside
Highest
Price Target
63 USD
47% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

QGEN Price
Qiagen NV

1M 1M
-1%
6M 6M
+8%
1Y 1Y
-7%
3Y 3Y
-12%
5Y 5Y
+6%
10Y 10Y
+107%
Annual Price Range
42.75
52w Low
35.55
52w High
47.24
Price Metrics
Average Annual Return 8.8%
Standard Deviation of Annual Returns 33.01%
Max Drawdown -39%
Shares Statistics
Market Capitalization 9.5B USD
Shares Outstanding 221 336 992
Percentage of Shares Shorted 1.82%

QGEN Return Decomposition
Main factors of price return

What is price return decomposition?

QGEN News

Other Videos

Last Important Events
Qiagen NV

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Qiagen NV

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Qiagen NV Logo
Qiagen NV

Country

Netherlands

Industry

Life Sciences Tools & Services

Market Cap

9.5B USD

Dividend Yield

2.94%

Description

QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company is headquartered in Venlo, Limburg and currently employs 6,028 full-time employees. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Contact

LIMBURG
Venlo
Hulsterweg 82
+31773556600.0
https://www.qiagen.com/

IPO

1996-09-01

Employees

6 028

Officers

CEO, MD & Member of Management Board
Mr. Thierry Bernard
CFO, MD & Member of Management Board
Dr. Roland Sackers
Senior VP & Head of Global Operations
Mr. Antonio Santos
Vice President of Corporate Communications & Investor Relations
Mr. John Gilardi
Senior VP & Head of Human Resources
Ms. Stephany Foster
Senior Vice President of Life Science Business Area
Dr. Thomas Schweins
Show More
Senior Director & Head of External Communications
Dr. Thomas Theuringer
Senior VP & Head of Molecular Diagnostics Business Area
Mr. Jean-Pascal Viola
Senior Vice President of Qiagen Digital Insights Business Area
Dr. Jonathan G. Sheldon Ph.D.
Vice President of Global Treasury
Mr. Thomas Neidert
Show Less

See Also

Discover More
What is the Intrinsic Value of one QGEN stock?

The intrinsic value of one QGEN stock under the Base Case scenario is 41.48 USD.

Is QGEN stock undervalued or overvalued?

Compared to the current market price of 42.75 USD, Qiagen NV is Overvalued by 3%.